Comparing Cuvitru vs Xembify
| Cuvitru (immune globulin subcutaneous) | Xembify (immune globulin subcutaneous) |
|
|---|
| Cuvitru (immune globulin subcutaneous) | Xembify (immune globulin subcutaneous) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Primary Immunodeficiency Syndrome. Cuvitru may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Primary Immunodeficiency Syndrome. Xembify may also be used for purposes not listed in this medication guide. |
||||||||||||||||
| More about Cuvitru (immune globulin subcutaneous) | More about Xembify (immune globulin subcutaneous) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Cuvitru has an average rating of 8.8 out of 10 from a total of 13 ratings on Drugs.com. 77% of reviewers reported a positive effect, while 0% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Cuvitru side effects |
View all Xembify side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Cuvitru prices |
View all Xembify prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other immune globulin subcutaneous brands include: Cutaquig, Hizentra, Xembify | Other immune globulin subcutaneous brands include: Cutaquig, Cuvitru, Hizentra | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
564 hours |
564 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 22 drugs are known to interact with Cuvitru:
|
A total of 22 drugs are known to interact with Xembify:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.